# Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center

> **NCT03889470** · PHASE4 · UNKNOWN · sponsor: **Hermina Heart Center Kemayoran** · enrollment: 1000 (estimated)

## Conditions studied

- Radial Artery Injury

## Interventions

- **DRUG:** NTG 1 MG/ML Injectable Solution

## Key facts

- **NCT ID:** NCT03889470
- **Lead sponsor:** Hermina Heart Center Kemayoran
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-31
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-10-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2019-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03889470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03889470, "Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03889470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*